Skip to main content
. 2023 Jul 26;229(2):346–354. doi: 10.1093/infdis/jiad281

Figure 2.

Figure 2.

Proportions of RSV-seronegative vaccinees and placebo recipients with indicated illnesses during the first 28 days postvaccination. Vaccinees are shown in black; placebo recipients are shown in gray. Abbreviations: LRI, lower respiratory illness; RSV, respiratory syncytial virus.